Arca biopharma says fda issued special protocol assessment agreement for single phase 3 clinical trial for precision-af

Arca biopharma announces fiscal year 2019 financial results and provides corporate update.arca biopharma inc - u.s. fda issued a special protocol assessment (spa) agreement for a single phase 3 clinical trial for precision-af.arca biopharma inc - arca anticipates initiating precision-af in q4 of 2020.arca biopharma- will need to raise additional capital, complete partnership or other possible strategic transaction, to fund future operations.
ABIO Ratings Summary
ABIO Quant Ranking